Smoking increases the treatment failure for Helicobacter pylori eradication

American Journal of Medicine

Volumn 119, Issue 3, 2006, Pages 217-224

  Suzuki, Takeshi ^a,b   Matsuo, Keitaro ^a   Ito, Hidemi ^a   Sawaki, Akira ^a   Hirose, Kaoru ^a   Wakai, Kenji ^a   Sato, Shigeki ^b   Nakamura, Tsuneya ^a   Yamao, Kenji ^a   Ueda, Ryuzo ^b   Tajima, Kazuo ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

Author keywords

Helicobacter pylori; Heterogeneity; Meta analysis; Smoking

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; BISMUTH CITRATE; CETRAXATE; CLARITHROMYCIN; FURAZOLIDONE; LANSOPRAZOLE; METRONIDAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; RANITIDINE BISMUTH CITRATE; TETRACYCLINE; TINIDAZOLE;

CLINICAL TRIAL; DYSPEPSIA; ERADICATION THERAPY; GEOGRAPHIC DISTRIBUTION; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SMOKING; STATISTICAL ANALYSIS; SYSTEMATIC REVIEW; TREATMENT FAILURE; ULCER;

ANTI-BACTERIAL AGENTS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; PROTON PUMPS; RANDOMIZED CONTROLLED TRIALS; SMOKING; TREATMENT FAILURE;

EID: 32844461824     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.10.003     Document Type: Review

References (51)

1. B.J. Marshall, J.R. Warren Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration Lancet 1 1984 1311 1315
2. A.C. Wotherspoon, C. Ortiz-Hidalgo, M.R. Falzon, P.G. Isaacson Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma Lancet 338 1991 1175 1176
3. J. Parsonnet, G.D. Friedman, D.P. Vandersteen Helicobacter pylori infection and the risk of gastric carcinoma N Engl J Med 325 1991 1127 1131
4. J.P. Gisbert, L. Gonzalez, X. Calvet Systematic review and meta-analysis proton pump inhibitor vs. ranitidine bismuth citrate plus two antibiotics in Helicobacter pylori eradication Helicobacter 10 2005 157 171
5. D.Y. Graham, G.M. Lew, H.M. Malaty Factors influencing the eradication of Helicobacter pylori with triple therapy Gastroenterology 102 1992 493 496
6. T. Lind, F. Megraud, P. Unge The MACH2 study role of omeprazole in eradication of Helicobacter pylori with 1-week triple therapies Gastroenterology 116 1999 248 253
7. N. Broutet, S. Tchamgoue, E. Pereira Risk factors for failure of Helicobacter pylori therapy-results of an individual data analysis of 2751 patients Aliment Pharmacol Ther 17 2003 99 109
8. C.K. Lin, P.I. Hsu, K.H. Lai One-week quadruple therapy is an effective salvage regimen for Helicobacter pylori infection in patients after failure of standard triple therapy J Clin Gastroenterol 34 2002 547 551
9. L.J. van Doorn, P.M. Schneeberger, N. Nouhan Importance of Helicobacter pylori cagA and vacA status for the efficacy of antibiotic treatment Gut 46 2000 321 326
10. N. Broutet, A. Marais, H. Lamouliatte cagA Status and eradication treatment outcome of anti-Helicobacter pylori triple therapies in patients with nonulcer dyspepsia J Clin Microbiol 39 2001 1319 1322
11. P. Moayyedi, D.M. Chalmers, A.T. Axon Patient factors that predict failure of omeprazole, clarithromycin, and tinidazole to eradicate Helicobacter pylori J Gastroenterol 32 1997 24 27
12. T. Kamada, K. Haruma, K. Komoto Effect of smoking and histological gastritis severity on the rate of H. pylori eradication with omeprazole, amoxicillin, and clarithromycin Helicobacter 4 1999 204 210
13. G. Maconi, F. Parente, A. Russo Do some patients with Helicobacter pylori infection benefit from an extension to 2 weeks of a proton pump inhibitor-based triple eradication therapy? Am J Gastroenterol 96 2001 359 366
14. F. Perri, M.R. Villani, V. Festa Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy' Aliment Pharmacol Ther 15 2001 1023 1029
15. G. Treiber, J. Wittig, S. Ammon Clinical outcome and influencing factors of a new short-term quadruple therapy for Helicobacter pylori eradication a randomized controlled trial (MACLOR study) Arch Intern Med 162 2002 153 160
16. S.B. Lee, S.J. Park, J.K. Ryu Efficacy of triple therapy with rabeprazole for Helicobacter pylori infection in relation to CYP2C19 genotype Korean J Gastroenterol 42 2003 468 475
17. V. De Francesco, A. Zullo, C. Hassan The prolongation of triple therapy for Helicobacter pylori does not allow reaching therapeutic outcome of sequential scheme a prospective, randomised study Dig Liver Dis 36 2004 322 326
18. M.J. Janssen, R.J. Laheij, J.B. Jansen, W.A. de Boer The influence of pretreatment on cure rates of Helicobacter pylori eradication Neth J Med 62 2004 192 196
19. T.T. Koivisto, H.I. Rautelin, M.E. Voutilainen First-line eradication therapy for Helicobacter pylori in primary health care based on antibiotic resistance results of three eradication regimens Aliment Pharmacol Ther 21 2005 773 782
20. G. Manes, O. Pieramico, F. Perri Twice-daily standard dose of omeprazole achieves the necessary level of acid inhibition for Helicobacter pylori eradication. A randomized controlled trial using standard and double doses of omeprazole in triple therapy Dig Dis Sci 50 2005 443 448
21. G. Bertoni, R. Sassatelli, E. Nigrisoli Triple therapy with azithromycin, omeprazole, and amoxicillin is highly effective in the eradication of Helicobacter pylori a controlled trial versus omeprazole plus amoxicillin Am J Gastroenterol 91 1996 258 263
22. R. DerSimonian, N. Laird Meta-analysis in clinical trials. Prognostic role of antibody reactivity to melanoma Control Clin Trials 7 1986 177 188
23. S.G. Thompson, S.J. Sharp Explaining heterogeneity in meta-analysis a comparison of methods Stat Med 18 1999 2693 2708
24. C.B. Begg, M. Mazumdar Operating characteristics of a rank correlation test for publication bias Biometrics 50 1994 1088 1101
25. F.W. Kirstein, H.J. Epple, C. Bojarski Dual versus triple therapy comparison of five antibiotic regimens for eradication of Helicobacter pylori in a prospective, randomized study Z Gastroenterol 36 1998 803 809
26. A.F. Cutler, T.T. Schubert Patient factors affecting Helicobacter pylori eradication with triple therapy Am J Gastroenterol 88 1993 505 509
27. H.J. O'Connor, C. Kanduru, A.S. Bhutta Effect of Helicobacter pylori eradication on peptic ulcer healing Postgrad Med J 71 1995 90 93
28. C.A. Fallone, A.N. Barkun, G. Friedman Is Helicobacter pylori eradication associated with gastroesophageal reflux disease? Am J Gastroenterol 95 2000 914 920
29. J.P. Gisbert, L. Gonzalez, X. Calvet Proton pump inhibitor, clarithromycin and either amoxycillin or nitroimidazole a meta-analysis of eradication of Helicobacter pylori Aliment Pharmacol Ther 14 2000 1319 1328
30. S.P. Kaushik, C. Vu Helicobacter pylori eradication with lansoprazole, amoxycillin and clarithromycin testing an ideal regimen in a multicultural south east Asian population and examining factors potentially influencing eradication Aust N Z J Med 30 2000 231 235
31. J.M. Baena, C. Lopez, A. Hidalgo Relation between alcohol consumption and the success of Helicobacter pylori eradication therapy using omeprazole, clarithromycin and amoxicillin for 1 week Eur J Gastroenterol Hepatol 14 2002 291 296
32. D.M. Queiroz, R. Dani, L.D. Silva Factors associated with treatment failure of Helicobacter pylori infection in a developing country J Clin Gastroenterol 35 2002 315 320
33. G.J. Mantzaris, K. Petraki, E. Archavlis Omeprazole triple therapy versus omeprazole quadruple therapy for healing duodenal ulcer and eradication of Helicobacter pylori infection a 24-month follow-up study Eur J Gastroenterol Hepatol 14 2002 1237 1243
34. C.J. Wu, P.I. Hsu, G.H. Lo Comparison of cetraxate-based and pantoprazole-based triple therapies in the treatment of Helicobacter pylori infection J Chin Med Assoc 67 2004 161 167
35. K. Endoh, G.L. Kauffman Jr, F.W. Leung Mechanism of aggravation of mucosal injury by intravenous nicotine in rat stomach Am J Physiol 261 1991 G1037 G1042
36. L. Holm, M.A. Perry Role of blood flow in gastric acid secretion Am J Physiol 254 1988 G281 G293
37. F. Parente, M. Lazzaroni, O. Sangaletti Cigarette smoking, gastric acid secretion, and serum pepsinogen I concentrations in duodenal ulcer patients Gut 26 1985 1327 1332
38. J. Labenz, M. Stolte, A.L. Blum Intragastric acidity as a predictor of the success of Helicobacter pylori eradication a study in peptic ulcer patients with omeprazole and amoxicillin Gut 37 1995 39 43
39. J. van der Weide, L.S. Steijns Cytochrome P450 enzyme system genetic polymorphisms and impact on clinical pharmacology Ann Clin Biochem 36 1999 722 729
40. S. Zevin, N.L. Benowitz Drug interactions with tobacco smoking. An update Clin Pharmacokinet 36 1999 425 438
41. P.H. Villard, E.M. Seree, J.L. Re Effects of tobacco smoke on the gene expression of the Cyp1a, Cyp2b, Cyp2e, and Cyp3a subfamilies in mouse liver and lung relation to single strand breaks of DNA Toxicol Appl Pharmacol 148 1998 195 204
42. T. Furuta, K. Ohashi, T. Kamata Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer Ann Intern Med 129 1998 1027 1030
43. M. Sagar, G. Tybring, M.L. Dahl Effects of omeprazole on intragastric pH and plasma gastrin are dependent on the CYP2C19 polymorphism Gastroenterology 119 2000 670 676
44. P. Degoulet, J. Menard, H.A. Vu Factors predictive of attendance at clinic and blood pressure control in hypertensive patients Br Med J 287 1983 88 93 (Clin Res Ed)
45. S.J. Konturek, W. Bielanski, M. Plonka Helicobacter pylori, non-steroidal anti-inflammatory drugs and smoking in risk pattern of gastroduodenal ulcers Scand J Gastroenterol 38 2003 923 930
46. N. Hamajima, K. Matsuo, T. Saito Interleukin 1 polymorphisms, lifestyle factors, and Helicobacter pylori infection Jpn J Cancer Res 92 2001 383 389
47. M. Nakamura, K. Haruma, T. Kamada Cigarette smoking promotes atrophic gastritis in Helicobacter pylori-positive subjects Dig Dis Sci 47 2002 675 681
48. K. Endoh, F.W. Leung Effects of smoking and nicotine on the gastric mucosa a review of clinical and experimental evidence Gastroenterology 107 1994 864 878
49. K. Matsuo, N. Hamajima, Y. Ikehara Smoking and polymorphisms of fucosyltransferase gene Le affect success of H. pylori eradication with lansoprazole, amoxicillin, and clarithromycin Epidemiol Infect 130 2003 227 233
50. H. Lamouliatte, R. Samoyeau, A. De Mascarel, F. Megraud Double vs. single dose of pantoprazole in combination with clarithromycin and amoxycillin for 7 days, in eradication of Helicobacter pylori in patients with non-ulcer dyspepsia Aliment Pharmacol Ther 13 1999 1523 1530
51. T. Azuma Helicobacter pylori CagA protein variation associated with gastric cancer in Asia J Gastroenterol 39 2004 97 103